Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Haisma

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
The Prostate|September 25, 2004
Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitroR Kraaij, A L C T van Rijswijk, M H A Oomen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2007
Towards a double controlled conditionally replicative adenovirus for potent and specific melanoma cell killW M Gommans, D Oosterhuis, I Dmitriev, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancerH J Haisma, K R Moseley, A I Battaile, et al.
Bioorganic & Medicinal Chemistry|February 1, 1997
Synthesis and biological activity of beta-glucuronyl carbamate-based prodrugs of paclitaxel as potential candidates for ADEPTD B de Bont, R G Leenders, H J Haisma, et al.
FEBS Letters|December 28, 1993
A new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugsM H Vingerhoeds, H J Haisma, M van Muijen, et al.
British Journal of Cancer|September 1, 1992
A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancerH J Haisma, E Boven, M van Muijen, et al.
Cancer Gene Therapy|July 6, 2000
Targeting of adenoviral vectors through a bispecific single-chain antibodyH J Haisma, J Grill, D T Curiel, et al.
British Journal of Cancer|December 23, 1998
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenograftsP H Houba, E Boven, C A Erkelens, et al.
Gene Therapy|January 11, 2000
Recombinant adenovirus vectors with knobless fibers for targeted gene transferV W van Beusechem, A L van Rijswijk, H H van Es, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1997
Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude miceW E Meijs, H J Haisma, R P Klok, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The Prostate|September 25, 2004
Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitroR Kraaij, A L C T van Rijswijk, M H A Oomen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2007
Towards a double controlled conditionally replicative adenovirus for potent and specific melanoma cell killW M Gommans, D Oosterhuis, I Dmitriev, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancerH J Haisma, K R Moseley, A I Battaile, et al.
Bioorganic & Medicinal Chemistry|February 1, 1997
Synthesis and biological activity of beta-glucuronyl carbamate-based prodrugs of paclitaxel as potential candidates for ADEPTD B de Bont, R G Leenders, H J Haisma, et al.
FEBS Letters|December 28, 1993
A new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugsM H Vingerhoeds, H J Haisma, M van Muijen, et al.
British Journal of Cancer|September 1, 1992
A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancerH J Haisma, E Boven, M van Muijen, et al.
Cancer Gene Therapy|July 6, 2000
Targeting of adenoviral vectors through a bispecific single-chain antibodyH J Haisma, J Grill, D T Curiel, et al.
British Journal of Cancer|December 23, 1998
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenograftsP H Houba, E Boven, C A Erkelens, et al.
Gene Therapy|January 11, 2000
Recombinant adenovirus vectors with knobless fibers for targeted gene transferV W van Beusechem, A L van Rijswijk, H H van Es, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1997
Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude miceW E Meijs, H J Haisma, R P Klok, et al.
Pageof 8